NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older.

Authors

Margery L S Gass, The North American Menopause Society Cleveland Clinic Center for Specialized Women’s Health Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland, Ohio
Pauline M Maki, Women’s Mental Health Research UIC Center for Research in Women and Gender University of Illinois Chicago, Illinois
Jan L Shifren, Harvard Medical School Massachusetts General Hospital Midlife Women’s Health Center Boston, Massachusetts
Peter F Schnatz, Department of Obstetrics and Gynecology and Internal Medicine Reading Hospital Reading, Pennsylvania
Andrew M Kaunitz, Department of Obstetrics and Gynecology University of Florida College of Medicine Jacksonville, Florida
Marla Shapiro, Department of Family and Community Medicine University of Toronto Toronto, Ontario, Canada
Lynnette Leidy Sievert, Department of Anthropology University of Massachusetts Amherst, Massachusetts

Document Type

Article

Publication Date

7-1-2015

Publication Title

Menopause (New York, N.Y.)

Volume

22

Issue

7

First Page

685

Last Page

686

Recommended Citation

Gass, M., Maki, P., Shifren, J., Schnatz, P., Kaunitz, A., Shapiro, M., & Sievert, L. (2015). NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older.. Menopause (New York, N.Y.), 22 (7), 685-686. https://doi.org/https://doi.org/10.1097/GME.0000000000000491